Logo for Chimerix Inc

Chimerix Investor Relations Material

Latest events

Logo for Chimerix Inc

FDA Announcement

Chimerix
Logo for Chimerix

FDA Announcement

10 Dec, 2024
Logo for Chimerix

Q3 2024

7 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Chimerix Inc

Access all reports
Chimerix Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases, including viral infections and cancer. The company's portfolio includes antiviral treatments and oncology therapies aimed at addressing unmet medical needs. Chimerix works on developing novel drug candidates to improve outcomes for patients with limited treatment options, particularly in areas such as immunotherapy and targeted therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.